Both in Biotechnology
Immunovant vs CG Oncology
Over the past year IMVT returned +23.8% and CGON returned +58.5%; their daily moves had a correlation of 0.38.
IMVT +23.8% CGON +58.5%Growth of $1, one year, split-adjusted
| Metric | IMVT | CGON |
|---|---|---|
| Price | $29.44 | $66.40 |
| Market cap | $6.08B | $5.89B |
| Today | +1.36% | +3.65% |
| 1 month | −8.3% | +4.3% |
| 6 months | +2.7% | −2.4% |
| Year to date | +15.8% | +59.9% |
| 1 year | +23.8% | +58.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | −239.2% |
| Net margin | — | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 945.0× |
| Net cash | $797.8M | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 42.3% |
| Short % of float | 21.1% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).